논문KCI 등재
Correspondence to editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (8)
관련 논문AI추천
Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Chih-Cheng Lai, Chi-Kuei Hsu, Po-Yu Huang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Jian-Gao Fan, Jing Zeng대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Weixiong Zhu, Wence Zhou, Xuefan Zeng, Yusheng Cheng, Zengxi Yang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Ailei Xu, Wei Wang, Yating Xie대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Jian-Gao Fan, Jing Zeng대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”Dae Won Jun, Yuri Cho대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133